Multiplexing Technology Firm Genalyte Raises $11.8M in Series B Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genalyte today announced the completion of a Series B financing that raised $11.8 million.

The funds will primarily go toward commercializing its Maverick platform and highly multiplexed panels for autoimmune and immunoassay applications, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.